• Skip to primary navigation
  • Skip to main content
  • Skip to footer
AKRN

AKRN

Scientific Consulting

  • Services
    • Clinical Services
    • Regulatory Services
    • Quality Management Services
    • Medical Writing
    • Clinical Data Management
    • Statistical Analysis and Reporting
    • Medical Aesthetic Devices
    • COVID-19
  • Team
    • Who we are
    • Our team
    • Code of Ethics
    • Our history
    • Our Community
  • News
    • News
    • Resources
    • Social Network
  • Career Portal
  • Contact
  • English
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

“Want to See the Future of Digital Health Tools? Look to Germany”: A Review

August 27, 2021 by AKRN

D. Stern, Matthies, Julia Hagen, Brönneke, and F. Debatin depict the point of inflexion that the Digitale-Versorgung-Gesetz (DVG) will prospectively poise in global health care in their article ‘Want to See the Future of Digital Health Tools? Look to Germany’. Prior to the DVG, the German health care system was hinged by a severe comparative lag in digital advances; there simply was no incentive for manufacturers to adventure into a system that so heavily lacked the support of the medical community.

Perhaps if Covid had not happened, these laws would have passed unrecognized, however, the catalytic effect of the pandemic only evidenced the benefits that this digital development entails, in particular the gap that exists in the market for a remote monitoring scheme that will survive a lockdown (or several).

The increase in the number of apps employed in monitoring and care delivery will subsequently create an immense pool of ‘real world data’ which may debunk data from randomized controlled trials as the gold standard for regulatory decisions about new health care products.

This holds a risk; it opens the barriers for all software to accumulate real-world data of medical importance, which may lead to an increase of inefficient software holding personal information. Although this risk will not easily disappear, for any app to be included in the DIGA registry and to qualify for insurance coverage it must first obtain the CE mark, barriers of which have been raised by the recent enforcement of the MDR. In addition, it must demonstrate it secures data protection, information security, interoperability, and preliminary data on the benefits that the app provides. In other words, manufacturers are incentivised, but safety and efficacy are still protected by law.

Digital health. Software as tool to accumulate real-world data of medical importance

Source: Harvard Business Review.

Subject Matter Expert

Maria Nyåkern, Ph.D. Founder & Executive Director LinkedIn

Share this article

Category iconUncategorized

Request a free consultation

Our team will help you to find the best solution for your needs. Our medical device experience and clinical knowledge can help you plan, set up, and execute a clinical trial, or performance study, in an optimal way.

Footer

AKRN Spain

AKRN Scientific Consulting S.L.
Address: Calle de Fuerteventura 4 (office 1.8)
Office Park La Marina
Postal Code: ES-28703 Madrid
Phone: +34 910 25 81 40
VAT ID: ES-B87990925

Contact details

Contact email: contact@akrnconsulting.com
Office phone: +34 910 258 140
Office phone: +34 911 136 635
Go to contact

Content

  • Medical Device Consulting Services
  • Clinical Studies for Medical Devices
  • Medical Writing
  • Regulatory Services
  • Contact

Resources

  • Articles
  • Resources
  • Career Portal

Latest articles

  • NEW AEMPS INSTRUCTION FOR MANUFACTURING LICENSE
  • DEVELOP AND IMPLEMENT YOUR QMS ACCORDING TO ISO 13485
  • Summary of Safety and Clinical Performance (SSCP/SSP)
  • Essential documents according to ISO 14155:2020
  • Roadmap to CE marking for medical devices and IVDs
  • The quality management system according to ISO 13485

AKRN Scientific Consulting S.L ha sido beneficiaria del Fondo Europeo de Desarrollo Regional cuyo objetivo es mejorar la competitividad de las Pymes y gracias al cual ha puesto en marcha un Plan de Marketing Digital Internacional con el objetivo de mejorar su posicionamiento online en mercados exteriores durante el año 2020. Para ello ha contado con el apoyo del Programa XPANDE DIGITAL de la Cámara de Comercio de Burgos.
“Una manera de hacer Europa”

AKRN Scientific Consulting S.L ha sido beneficiaria de la subvención de contratos de trabajo de la Comunidad de Madrid, cofinanciado por el Fondo Social Europeo y la Iniciativa de Empleo Juvenil, en el marco del Programa Operativo de Empleo Juvenil 2014-2020, gestionado por la Consejería de Economía, Empleo y Hacienda.

La empresa (AKRN Scientific Consulting S.L.) es beneficiaria del Programa “la Caixa” Empleo Joven de ayudas para el fomento de la contratación de personas jóvenes. Estas ayudas están cofinanciadas por el Programa Operativo de Empleo Juvenil / Iniciativa de Empleo Juvenil – Fondo Social Europeo y por la Fundación Bancaria “la Caixa”.

 

 

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Privacy policy – Cookie Policy – Legal Notice –  Copyright © 2022. All rights reserved. Return to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview
AKRN

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy